首页 | 本学科首页   官方微博 | 高级检索  
     


RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database
Authors:Vicenç Torrente-Segarra  Ana Urruticoechea Arana  Amalia Sánchez-Andrade Fernández  Juan Víctor Tovar Beltrán  Alejandro Muñoz Jiménez  Anna Martínez-Cristóbal
Affiliation:1. Rheumatology Department, Hospital General Hospitalet-Sant Joan Despí Moisès Broggi, Catalunya, Spain, vtorrente@hsjdbcn.org vicente.torrentesegarra@sanitatintegral.org;3. Rheumatology Department, Hospital Can Misses, Ibiza, Spain,;4. Rheumatology Department, Complejo Hospital Universitario Lucus Augusti, Lugo, Spain,;5. Rheumatology Department, Hospital General Universitario de Elche, Elche, Spain,;6. Rheumatology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain,;7. Rheumatology Department, Hospital de la Ribera, Alzira, Spain,
Abstract:
Keywords:Certolizumab PEGol  Clinical practice  Efficacy  Rheumatoid arthritis  Safety  Spanish population  Survival rate
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号